1. Home
  2. ZURA vs CRMT Comparison

ZURA vs CRMT Comparison

Compare ZURA & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • CRMT
  • Stock Information
  • Founded
  • ZURA 2022
  • CRMT 1981
  • Country
  • ZURA United States
  • CRMT United States
  • Employees
  • ZURA N/A
  • CRMT N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • CRMT Other Specialty Stores
  • Sector
  • ZURA Health Care
  • CRMT Consumer Discretionary
  • Exchange
  • ZURA Nasdaq
  • CRMT Nasdaq
  • Market Cap
  • ZURA 69.9M
  • CRMT 389.6M
  • IPO Year
  • ZURA N/A
  • CRMT N/A
  • Fundamental
  • Price
  • ZURA $1.32
  • CRMT $60.88
  • Analyst Decision
  • ZURA Buy
  • CRMT Hold
  • Analyst Count
  • ZURA 7
  • CRMT 1
  • Target Price
  • ZURA $14.33
  • CRMT $50.00
  • AVG Volume (30 Days)
  • ZURA 659.9K
  • CRMT 144.6K
  • Earning Date
  • ZURA 08-08-2025
  • CRMT 06-12-2025
  • Dividend Yield
  • ZURA N/A
  • CRMT N/A
  • EPS Growth
  • ZURA N/A
  • CRMT N/A
  • EPS
  • ZURA N/A
  • CRMT 2.33
  • Revenue
  • ZURA N/A
  • CRMT $1,390,932,000.00
  • Revenue This Year
  • ZURA N/A
  • CRMT $1.95
  • Revenue Next Year
  • ZURA N/A
  • CRMT $10.30
  • P/E Ratio
  • ZURA N/A
  • CRMT $26.14
  • Revenue Growth
  • ZURA N/A
  • CRMT 0.14
  • 52 Week Low
  • ZURA $0.97
  • CRMT $36.40
  • 52 Week High
  • ZURA $5.07
  • CRMT $72.26
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 63.32
  • CRMT 66.47
  • Support Level
  • ZURA $1.00
  • CRMT $59.63
  • Resistance Level
  • ZURA $1.22
  • CRMT $62.72
  • Average True Range (ATR)
  • ZURA 0.09
  • CRMT 2.26
  • MACD
  • ZURA 0.02
  • CRMT 0.68
  • Stochastic Oscillator
  • ZURA 95.45
  • CRMT 87.20

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and in the majority of the cases a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

Share on Social Networks: